Loading...
Loading...
Application UK00004337147 · Application Published

| Application Number | UK00004337147 |
| Status | Application Published |
| Owner | Nicholas Blair Rudlin |
| Filed | 2026-02-07 |
| Type | Individual |
| Feature | Figurative |
8 8TH HOUSE has a current status of Application Published.
The specification below is taken directly from the filed record at the UK IPO for each Nice class this trademark is registered in.
Pharmaceuticals;Homeopathic pharmaceuticals;Injectable pharmaceuticals;Pharmaceutical drugs;Anti-diabetic pharmaceuticals;Antidiabetic pharmaceuticals;Antibacterial pharmaceuticals;Cardiovascular pharmaceuticals;Ocular pharmaceuticals;Pharmaceutical preparations and substances for use in oncology;Pharmaceutical preparations and substances for use in urology;Dermatological pharmaceutical substances;Chemicals for pharmaceutical use;Pharmaceutical preparations and substances for use in gynecology;Astringents [pharmaceutical];Pharmaceutical creams;Gelatin capsules for pharmaceuticals;Pharmaceutical preparations and substances;Dermatological pharmaceutical products;Pharmaceuticals for the treatment of erectile dysfunction;Lotions for pharmaceutical purposes;Pharmaceutical implants;Pharmaceuticals and natural remedies;Pharmaceutical preparations for use in oncology;Pharmaceutical preparations for use in urology;Pharmaceutical products for the treatment of cancer;Ointments for pharmaceutical purposes;Empty capsules for pharmaceuticals;Pharmaceutical sweets;Analgesics for pharmaceutical use;Pharmaceutical preparations and substances for use in the field of anesthesia;Cytostatics for pharmaceutical purposes;Antibacterials for pharmaceutical use;Pharmaceutical products for the treatment of depression;Pharmaceutical preparations and substances for the treatment of cancer;Pharmaceutical products for the treatment of bone diseases;Food esters for pharmaceutical purposes;Iodine for pharmaceutical purposes;Implantable medicines;Pharmaceutical preparations for inhalers;Pharmaceutical preparations for use in hematology;Pharmaceutical preparations and substances for the treatment of gastro-intestinal diseases;Pharmaceutical preparations for animals;Elixirs [pharmaceutical preparations];Pharmaceutical preparations;Pharmaceutical products and preparations for chloasma;Alkaloids used for pharmaceutical purposes;Phosphates for pharmaceutical purposes;Sulphonamides [medicines];Sulphonamides as medicines;Iodides for pharmaceutical purposes;Pharmaceutical antiallergic preparations and substances;Sandalwood oil for medical, pharmaceutical and veterinary purposes;Capsules made of dendrimer-based polymers, for pharmaceuticals;Synthetic peptides for pharmaceutical purposes;Pharmaceutical preparations for use in dermatology;Pharmaceutical products for ophthalmological use;Alginate tablets for pharmaceutical purposes;Pharmaceutical products for the treatment of infectious diseases;Alginates for pharmaceutical purposes;Pharmaceutical products for treating respiratory diseases;Anti-epileptic pharmaceutical preparations;Pharmaceutical solutions used in dialysis;Pharmaceutical preparations and substances for the prevention of cancer;Pharmaceutical preparations for use in chemotherapy;Cellulose for pharmaceutical purposes;Sulfonamides [medicines];Pharmaceutical compositions;Alcohol for pharmaceutical purposes;Tissues impregnated with pharmaceutical lotions;Lotions (Tissues impregnated with pharmaceutical -);Pharmaceutical products for the treatment of viral diseases;Bromine for pharmaceutical purposes;Pharmaceutical preparations for use in ophthalmology;Capsules for pharmaceutical purposes;Syrups for pharmaceutical purposes;Filled syringes for medical purposes [containing pharmaceuticals];Pharmaceutical preparations for veterinary use;Pharmaceutical preparations for treating chemical imbalances;Injectable pharmaceuticals for treatment of anaphylactic reactions;Pharmaceutical skin lotions;Ethers for pharmaceutical purposes;Parenteral anti-epileptic pharmaceutical preparations.
Business consultancy services;Business marketing services.
Medical nursing;Nursing, medical;Medical and healthcare clinics;Clinics (Medical -);Medical clinics;Medical counseling;Medical and healthcare services;Medical services;Medical examination;Medical examinations;Medical assistance;Health clinic services [medical];Medical counselling;Medical nursing services;Nursing services (Medical -);Medical clinic services;Clinic (Medical -) services;Clinic services (Medical -);Medical diagnostic services;Medical consultations;Medical treatment services;Medical information;Medical consultation;Medical testing;Medical care services;Medical screening;Remote monitoring of medical data for medical diagnosis and treatment;Medical imaging services;Health resort services [medical];Rental of medical and health care equipment;Medical services in the field of oncology;Medical assistance consultancy provided by doctors and other specialized medical personnel;Medical services in the field of nephrology;Medical counseling services;Medical health assessment services;Provision of medical treatment;Health farm services [medical];Medical advice in the field of pregnancy;Arranging of medical treatment;Medical examination of individuals;Medical care of feet;Providing medical support in the monitoring of patients receiving medical treatments;Medical evaluation services.
This figurative mark is indexed under the following Vienna categories by the UK IPO:
'8 8TH HOUSE' is a application published trademark on the UK IPO register, owned by Nicholas Blair Rudlin. The application (UK00004337147) was filed on 7 February 2026.
This mark is recorded under multiple classes: Class 5 (pharmaceuticals & medical preparations); Class 35 (advertising, business management & retail services); Class 44 (medical, veterinary & beauty services).
UK trademark UK00004337147 for the mark '8 8TH HOUSE' in Class 5, 35, 44 is recorded on the UK IPO register as owned by Nicholas Blair Rudlin. This covers one specific UK trademark record only — the same brand name may be owned by different parties in other classes, other countries, or as separate registrations.
No — the UK IPO records the status of UK trademark UK00004337147 for the mark '8 8TH HOUSE' as application published.
UK trademark UK00004337147 for the mark '8 8TH HOUSE' is recorded in Class 5 (pharmaceuticals & medical preparations); Class 35 (advertising, business management & retail services); Class 44 (medical, veterinary & beauty services). The filed specification reads: Class 5: Pharmaceuticals;Homeopathic pharmaceuticals;Injectable pharmaceuticals;Pharmaceutical drugs;Anti-diabetic pharmaceuticals;Antidiabetic pharmaceuticals;Antibacterial pharmaceuticals;Cardiovascular pharmaceuticals;Ocular pharmaceuticals;Pharmaceutical preparations and substances for use in oncology;Pharmaceut…
UK trademark UK00004337147 for the mark '8 8TH HOUSE' was filed at the UK IPO on 7 February 2026.
The UK IPO first published / advertised UK trademark UK00004337147 for the mark '8 8TH HOUSE' on 27 February 2026.
UK trademark data is supplied by the Intellectual Property Office under the Open Government Licence v3.0.
The “About This Trademark” summary and FAQ above are AI-generated from the register data shown on this page. They are factual summaries only — always verify details against the official register before making legal decisions.